Raloxifene Up-Regulates the Mrna Expression of Osteoprotegerin in the Lumbar Vertebra of Ovariectomized Rats

商敏,杨欣,李亚珍,顾蓓,吴琼,廖秦平
DOI: https://doi.org/10.3969/j.issn.1006-7108.2006.06.018
2006-01-01
Abstract:Objective To establish a postmenopausal osteoporotic model of rats and investigate the effect of raloxifene(RLX) on the expression of OPG mRNA in lumbar vertebra of ovariectomized rats, and to analyze its mechanism in the prevention of postmenopausal osteoporosis.Methods Forty female rats of 6-month-old were randomly allocated into 4 groups: sham operated group, ovariectomized group(OVX), ovariectomized +valerate estradiol group(OVX+E_2), and ovariectomized + raloxifene group(OVX+RLX). All rats were sacrificed after lavaged for 13 weeks. The fourth lumbar vertebra was dissected for histomorphology and the second lumbar vertebra for measurement of OPG mRNA by reverse transcription polymerase chain reaction technique.Results The trabecular volume% was significantly lower in the OVX group than that in the SHAM group, while the ostoid seam% was significantly higher (P0.05). The trabecular volume% was increased and ostoid seam% was reduced in OVX+E_2 group and OVX+RLX group. Compared with the SHAM rats, the OPG mRNA level was decreased significantly in the OVX group (P0.05), and E_2 and RXL up-regulated the expression of OPG mRNA significantly (P0.05).Conclusions The rat model of postmenopausal osteoporosis is successfully established. Valerate estradiol and RXL can inhibit bone turnover. OVX-induced bone loss is associated with OPG. Raloxifene, as well as valerate estradiol, might have anti-resorbtion effect on bone mediated by OPG.
What problem does this paper attempt to address?